Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor
申请人:SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
公开号:EP0657427A1
公开(公告)日:1995-06-14
A tricyclic indole-2-carboxylic acid derivative represented by the formula 1:
wherein X represents alkyl, halogen or cyano;
R¹ represents hydrogen, or a protecting group of carboxyl group;
W represents hydrogen, -CO₂R3i, -CONR3iR4i, -A-CO₂R3i or -A-CONR3iR4i, wherein -A- represents alkylene and R3i and R4i independently represent hydrogen, alkyl, aryl or substituted aryl,
or a pharmaceutically acceptable salt thereof, these compounds are selective antagonists of glycine binding site of the NMDA receptor.
式 1 所代表的三环吲哚-2-羧酸衍生物:
其中 X 代表烷基、卤素或氰基;
R¹ 代表氢或羧基保护基团;
W 代表氢、-CO₂R3i、-CONR3iR4i、-A-CO₂R3i 或 -A-CONR3iR4i,其中 -A- 代表亚烷基,R3i 和 R4i 独立地代表氢、烷基、芳基或取代的芳基、
或其药学上可接受的盐,这些化合物是 NMDA 受体甘氨酸结合位点的选择性拮抗剂。